These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

706 related articles for article (PubMed ID: 29902867)

  • 1. A single dose of the antineoplastics hydroxyurea or cisplatin has praziquantel-like effects on Schistosoma mansoni worms and host mouse liver.
    Eldeeb E; Fahmy S; Elbakry K; Hyder A
    Biomed Pharmacother; 2018 Mar; 99():570-575. PubMed ID: 29902867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Praziquantel decreases fecundity in Schistosoma mansoni adult worms that survive treatment: evidence from a laboratory life-history trade-offs selection study.
    Lamberton PHL; Faust CL; Webster JP
    Infect Dis Poverty; 2017 Jun; 6(1):110. PubMed ID: 28622767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of praziquantel treatment on the liver functions, worm burden, and granuloma size using two drug regimen in murine Schistosoma mansoni infection.
    el-Fakahany AF; Abdalla KF; el-Hady HM; Abd el-Aziz SM; Afifi LM
    J Egypt Soc Parasitol; 1993 Dec; 23(3):877-86. PubMed ID: 8308363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anthelmintic activity in vitro and in vivo of Baccharis trimera (Less) DC against immature and adult worms of Schistosoma mansoni.
    de Oliveira RN; Rehder VL; Oliveira AS; Jeraldo Vde L; Linhares AX; Allegretti SM
    Exp Parasitol; 2014 Apr; 139():63-72. PubMed ID: 24602876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-response relationship in Schistosoma mansoni juvenile and adult stages following limonin treatment in experimentally infected mice.
    Eraky MA; El-Kholy AA; Rashed GA; Hammam OA; Moharam AF; Abou-Ouf EA; Aly NS; Kishik SM; Abdallah KF; Hamdan DI
    Parasitol Res; 2016 Oct; 115(10):4045-54. PubMed ID: 27325399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo.
    Liang YS; Coles GC; Dai JR; Zhu YC; Doenhoff MJ
    J Helminthol; 2002 Dec; 76(4):327-33. PubMed ID: 12498638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schistosoma mansoni: In vivo evaluation of Phyllanthus amarus hexanic and ethanolic extracts.
    de Oliveira CNF; Frezza TF; Garcia VL; Figueira GM; Mendes TMF; Allegretti SM
    Exp Parasitol; 2017 Dec; 183():56-63. PubMed ID: 29074138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of mefloquine with praziquantel in the Schistosoma mansoni mouse model and in vitro.
    Keiser J; Manneck T; Vargas M
    J Antimicrob Chemother; 2011 Aug; 66(8):1791-7. PubMed ID: 21602552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of treatment with a Protein Tyrosine Kinase Inhibitor (Genistein) on acute and chronic experimental Schistosoma mansoni infection.
    Sobhy MMK; Mahmoud SS; El-Sayed SH; Rizk EMA; Raafat A; Negm MSI
    Exp Parasitol; 2018 Feb; 185():115-123. PubMed ID: 29331278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics of mefloquine and praziquantel combination therapy in mice harbouring juvenile and adult Schistosoma mansoni.
    el-Lakkany NM; el-Din SH; Sabra AN; Hammam OA
    Mem Inst Oswaldo Cruz; 2011 Nov; 106(7):814-22. PubMed ID: 22124553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a combination of the new antischistosomal drug Ro 15-5458 and praziquantel on different strains of Schistosoma mansoni infected mice.
    Kamel G; Metwally A; Guirguis F; Nessim NG; Noseir M
    Arzneimittelforschung; 2000 Apr; 50(4):391-4. PubMed ID: 10800639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo schistosomicidal activity of three novels 8-hydroxyquinoline derivatives against adult and immature worms of Schistosoma mansoni.
    Allam G; Eweas AF; Abuelsaad AS
    Parasitol Res; 2013 Sep; 112(9):3137-49. PubMed ID: 23793335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin growth factor inhibitor as a potential new anti-schistosoma drug: An in vivo experimental study.
    Elhenawy AA; Ashour RH; Nabih N; Shalaby NM; El-Karef AA; Abou-El-Wafa HS
    Biomed Pharmacother; 2017 Nov; 95():1346-1358. PubMed ID: 28946182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo evaluation of cnicin from blessed thistle (Centaurea benedicta) and its inclusion complexes with cyclodextrins against Schistosoma mansoni.
    Queiroz LS; Ferreira EA; Mengarda AC; Almeida ADC; Pinto PF; Coimbra ES; de Moraes J; Denadai ÂML; Da Silva Filho AA
    Parasitol Res; 2021 Apr; 120(4):1321-1333. PubMed ID: 33164156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of hepatic lesions after treatment of Schistosoma mansoni or Schistosoma japonicum infection in mice: a comparative study.
    Andrade ZA; Cox TM; Cheever AM
    Am J Trop Med Hyg; 1993 Jul; 49(1):1-9. PubMed ID: 8352381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antischistosomal and anti-inflammatory activity of garlic and allicin compared with that of praziquantel in vivo.
    Metwally DM; Al-Olayan EM; Alanazi M; Alzahrany SB; Semlali A
    BMC Complement Altern Med; 2018 Apr; 18(1):135. PubMed ID: 29703259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of artemether on Schistosoma mansoni: dose-efficacy relationship, and changes in worm morphology and histopathology.
    Xiao SH; Guo J; Chollet J; Wu JT; Tanner M; Utzinger J
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Jun; 22(3):148-53. PubMed ID: 15597709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parasitological and histo-pathological studies on schistosomiasis mansoni infected mice and treated with praziquatel and/or oltipraz.
    Morsy GH
    J Egypt Soc Parasitol; 2009 Aug; 39(2):687-701. PubMed ID: 19795775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of two trematodicidal drugs on the morphology and tegumentary ultrastructure of Schistosoma mansoni.
    Mansoury ST
    J Egypt Soc Parasitol; 1997 Apr; 27(1):233-41. PubMed ID: 9097545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Praziquantel-lipid nanocapsules: an oral nanotherapeutic with potential
    Amara RO; Ramadan AA; El-Moslemany RM; Eissa MM; El-Azzouni MZ; El-Khordagui LK
    Int J Nanomedicine; 2018; 13():4493-4505. PubMed ID: 30122922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.